Camurus to present at Jefferies 2023 Healthcare Conference London
Lund, Sweden — 1 November 2023 — Camurus (Nasdaq Stockholm; CAMX), a commercial-stage pharmaceutical company developing innovative medications for severe and chronic diseases, today announced that Fredrik Tiberg, President and Chief Executive Officer, will participate in a fireside chat about the company’s business progress and R&D pipeline developments at Jefferies 2023 Healthcare Conference in London on 15 November at 8:30-8:55 am local time (GMT). A live webcast of the presentation can be accessed via: https://wsw.com/webcast/jeff287/camx.st/2248776 For more informationFredrik